Two Sigma Advisers’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,264,900
Closed -$20.6M 2016
2025
Q4
$20.6M Buy
1,264,900
+65,000
+5% +$982K 0.04% 345
2025
Q3
$14M Sell
1,199,900
-614,700
-34% -$8.01M 0.03% 411
2025
Q2
$21M Buy
1,814,600
+69,800
+4% +$636K 0.04% 328
2025
Q1
$15.2M Buy
1,744,800
+508,600
+41% +$6.41M 0.03% 404
2024
Q4
$17.8M Buy
1,236,200
+873,200
+241% +$13.8M 0.04% 348
2024
Q3
$8.2M Buy
363,000
+141,700
+64% +$2.93M 0.02% 543
2024
Q2
$4.3M Buy
221,300
+198,800
+884% +$5.21M 0.01% 828
2024
Q1
$844K Buy
+22,500
New +$989K ﹤0.01% 1655
2023
Q3
Sell
-21,500
Closed -$1.2M 2579
2023
Q2
$1.2M Buy
+21,500
New +$1.16M ﹤0.01% 1462
2023
Q1
Sell
-7,100
Closed -$259K 2754
2022
Q4
$259K Sell
7,100
-38,300
-84% -$1.25M ﹤0.01% 2115
2022
Q3
$1.29M Buy
+45,400
New +$1.73M ﹤0.01% 1395
2021
Q2
Sell
-93,700
Closed -$17M 2703
2021
Q1
$17M Buy
93,700
+86,300
+1,166% +$14.9M 0.05% 401
2020
Q4
$1.05M Buy
+7,400
New +$1.07M ﹤0.01% 1547

Other funds holding TXG